Human Fatty Liver Disease: Old Questions and New Insights

Cohen, Jonathan C., Horton, Jay D., Hobbs, Helen H.·2011·Science

DOI 10.1126/science.1204265

Cited by (1,007)

Items 801–900 of 1,007

A simple transcriptomic signature able to predict drug-induced hepatic steatosis
Marta Benet, Marta Moya, María Teresa Donato, Agustín Lahoz, David Hervás, Carla Guzmán, M.J. Gómez-Lechón, José Vicente Castell, Ramiro Jover · 2014 · Archives of Toxicology
Feedback looping between ChREBP and PPARα in the regulation of lipid metabolism in brown adipose tissues
Katsumi Iizuka, Wudelehu Wu, Yukio Horikawa, Masayuki Saito, Jun Takeda · 2013 · Endocrine Journal
Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease
Dong Hyun Sinn, Geum‐Youn Gwak, Juhee Cho, Hee Jung Son, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo · 2014 · Atherosclerosis
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Xiaoying Wu, Donna L. Romero, Wojciech Swiatek, Irene J. Dorweiler, Chintan K. Kikani, Hana Sabic, Ben S. Zweifel, John McKearn, Jeremy T. Blitzer, G. Allen Nickols et al. · 2014 · Cell Reports
Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan
Ching‐Sheng Hsu, Jia‐Horng Kao · 2012 · Journal of the Formosan Medical Association
Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetes
Zhi Dong, Yanji Luo, Huasong Cai, Zhongwei Zhang, Zhenpeng Peng, Mengjie Jiang, Yanbing Li, Chang Li, Ziping Li, Shi‐Ting Feng · 2016 · Medicine
Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG/ PKC/JNK pathway
Mohammad A. Dallak · 2018 · Biomedicine & Pharmacotherapy
Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis
André Lopes Simão, Marta B. Afonso, Pedro Miguel Rodrigues, Margarida Gama‐Carvalho, Mariana Verdelho Machado, Helena Cortez‐Pinto, Cecília M. P. Rodrigues, Rui Eduardo Castro · 2019 · Journal of Molecular Medicine
Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis
Andrea Herrero-Cervera, Ángela Vinué, Deborah Jane Burks, Herminia González Navarro · 2019 · Diabetologia
Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El‐Demerdash · 2020 · Toxicology and Applied Pharmacology
Selenoprotein F knockout leads to glucose and lipid metabolism disorders in mice
Xiaoxiang Zheng, Bingyu Ren, Xiaoming Li, Huanhuan Yan, Qingguo Xie, Hongmei Liu, Jun Zhou, Jing Tian, Kaixun Huang · 2020 · JBIC Journal of Biological Inorganic Chemistry
A branched‐chain amino acid‐based metabolic score can predict liver fat in children and adolescents with severe obesity
Julia Lischka, Andrea Schanzer, Azadeh Hojreh, Ahmed Ba Ssalamah, Chike Bellarmine Item, Charlotte de Gier, Nina‐Katharina Walleczek, Thomas F. Metz, Ivana Jakober, Susanne Greber‐Platzer et al. · 2020 · Pediatric Obesity
Lipid accumulation-induced hepatocyte senescence regulates the activation of hepatic stellate cells through the Nrf2-antioxidant response element pathway
Huiyuan Yu, Xin Jiang, Fangyuan Dong, Fan Zhang, Xueying Ji, Mengjuan Xue, Fan Yang, Jie Chen, Xiaona Hu, Zhijun Bao · 2021 · Experimental Cell Research
Methionine- and Choline-Deficient Diet–Induced Nonalcoholic Steatohepatitis Is Associated with Increased Intestinal Inflammation
Destiny Matthews, Honggui Li, Jing Zhou, Qingsheng Li, Shannon S. Glaser, Heather Francis, Gianfranco D. Alpini, Chaodong Wu · 2021 · American Journal Of Pathology
Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
Ping Chen, Yusheng Li, Li Xiao · 2021 · Experimental and Therapeutic Medicine
Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD
Simeng Wang, Qingzhang Zhu, Guosheng Liang, Tania Franks, Magalie Boucher, Kendra K. Bence, Mingjian Lu, Carlos M. Castorena, Shangang Zhao, Joel Keith Elmquist et al. · 2021 · Journal of Clinical Investigation
Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
Monique D. Appelman, Suzanne W. van der Veen, Saskia W. C. van Mil · 2021 · Frontiers in Endocrinology
Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein KinaseIn VivoandIn Vitro
Qin Feng, Xiaojun Gou, Shengxi Meng, Cheng Huang, Yuquan Zhang, Yajun Tang, Wenjing Wang, Lin Xu, Jinghua Peng, Yiyang Hu · 2013 · Evidence-based Complementary and Alternative Medicine
Longitudinal Effects of MRI-Measured Hepatic Steatosis on Biomarkers of Glucose Homeostasis and Hepatic Apoptosis in Obese Youth
Grace Kim, Cosimo Giannini, Bridget M. Pierpont, Ariel E. Feldstein, Nicola Santoro, Romy Kursawe, Melissa M. Shaw, Elvira J. Duran, Rachel L. Goldberg, James D Dziura et al. · 2012 · Diabetes Care
From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations
Charlotte Green, Camilla Pramfalk, Karl Morten, Leanne Hodson · 2014 · American Journal of Physiology-Endocrinology and Metabolism
Assessment of inflammation and fibrosis in non‐alcoholic fatty liver disease by imaging‐based techniques
Jeremy Cobbold, Dhupal Patel, Simon David Taylor-Robinson · 2012 · Journal of Gastroenterology and Hepatology
Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
Tadanobu Nagaya, Naoki Tanaka, Takefumi Kimura, Hiroyuki Kitabatake, Naoyuki Fujimori, Michiharu Komatsu, Akira Horiuchi, Takahiro Yamaura, Takeji Umemura, Kenji Sano et al. · 2015 · BBA Clinical
Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats
Chengyan Zhou, Jingjing Zhou, Na Han, Zhihui Liu, Bin Xiao, Jun Yin · 2015 · International Immunopharmacology
Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?
Parisa Shabani, H Naeimi Khaledi, Maani Beigy, Solaleh Emamgholipour, Eskandar Parvaz, Hossein Poustchi, Mahmood Doosti · 2015 · PLoS ONE
Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population
Yiling Li, Chao Xing, Zhong Tian, Hung-Chih Ku · 2012 · BMC Medical Genetics
Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model
Gonzalo Torres‐Villalobos, Nashla Hamdan‐Pérez, Armando Roberto Tovar, Guillermo Ordáz‐Nava, Braulio Martínez‐Benítez, Iván Torre-Villalvazo, Sofía Morán‐Ramos, Andrea Díaz‐Villaseñor, Lilia Guadalupe Noriega, Marcia Hiriart et al. · 2015 · Annals of Hepatology
Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review
Tongshuo Zhang, Hua-lei Qin, Tong Wang, Haitao Li, Hai Li, Shihai Xia, Xiao‐Hui Xiang · 2015 · SpringerPlus
Glucose-Raising Polymorphisms in the Human Clock Gene Cryptochrome 2 (CRY2) Affect Hepatic Lipid Content
Fausto E Machicao, Andreas Peter, Jürgen Machann, Ingmar Königsrainer, Anja Böhm, Stefan Zoltan Lutz, Martin Heni, Andreas Fritsche, Fritz Schick, Alfred Königsrainer et al. · 2016 · PLoS ONE
Lipophilic phosphorescent iridium(III) complexes as one- and two-photon selective bioprobes for lipid droplets imaging in living cells
Liang He, Jianjun Cao, Dongyang Zhang, Hao Liang, Mingfang Zhang, Cai‐Ping Tan, Liang‐Nian Ji, Zong‐Wan Mao · 2018 · Sensors and Actuators B Chemical
Chitobiose alleviates oleic acid-induced lipid accumulation by decreasing fatty acid uptake and triglyceride synthesis in HepG2 cells
Xiaodan Li, Mengyao Zhao, Liqiang Fan, Xuni Cao, Liehuan Chen, Junhui Chen, Y. Martin Lo, Liming Zhao · 2018 · Journal of Functional Foods
Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling
Yasuyo Urasaki, Chi Zhang, Ji‐Xin Cheng, Thuc T. Le · 2018 · Scientific Reports
Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models
Charlotte Green, Sion A. Parry, Pippa J. Gunn, Carlo D. L. Ceresa, Fredrik Rosqvist, Marie‐Ève Piché, Leanne Hodson · 2018 · Hormone Molecular Biology and Clinical Investigation
p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease
Zhibin Yan, Xiaokang Miao, Bangzhi Zhang, Junqiu Xie · 2018 · Life Sciences
Implantable Vascularized Liver Chip for Cross‐Validation of Disease Treatment with Animal Model
Jung Bok Lee, Jeong Su Park, Young Min Shin, Da Hyun Lee, Jeong‐Kee Yoon, Dae‐Hyun Kim, Ung Hyun Ko, YongTae Kim, Soo Han Bae, Hak‐Joon Sung · 2019 · Advanced Functional Materials
Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation
D. Erhartova, M. Cahová, H. Daňková, M. Heczková, I. Míková, E. Sticová, J. Spicak, O. Šeda, P. Trunec̃ka · 2019 · PLoS ONE
Chronic corticosterone exposure induces liver inflammation and fibrosis in association with m6A-linked post-transcriptional suppression of heat shock proteins in chicken
Yue Min Feng, Yun Hu, Zhen Hou, Qinwei Sun, Yimin Jia, Ruqian Zhao · 2019 · Cell Stress and Chaperones
PINE: An Automation Tool to Extract and Visualize Protein-Centric Functional Networks
Niveda Sundararaman, James L Go, Aaron Robinson, José María Mato, Shelly Chi-Loo Lu, Jennifer E. Van Eyk, Vidya Venkatraman · 2020 · Journal of the American Society for Mass Spectrometry
Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy
Xinxu Zhang, Yuanyuan Deng, Juan Xiang, Huixia Liu, Jiani Zhang, Jie Liao, Ke Chen, Bo Liu, Jun Liu, Ying Dong Pu · 2020 · Drug Design Development and Therapy
New Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells
Laura Vergani, Francesca Baldini, Mohamad Khalil, Adriana Voci, Pietro Putignano, Niccolò Miraglia · 2020 · Molecules
Metabolic insights from extreme human insulin resistance phenotypes
Anna J. Stears, Stephen O’Rahilly, Robert K. Semple, David B. Savage · 2012 · Best Practice & Research Clinical Endocrinology & Metabolism
Inhibitory Effects of Japanese Herbal Medicines Sho-saiko-to and Juzen-taiho-to on Nonalcoholic Steatohepatitis in Mice
Yoshihisa Takahashi, Yurie Soejima, Arisa Kumagai, Masato Watanabe, Hiroshi Uozaki, Toshio Fukusato · 2014 · PLoS ONE
Uridine Prevents Fenofibrate-Induced Fatty Liver
Thuc T. Le, Yasuyo Urasaki, Giuseppe Pizzorno · 2014 · PLoS ONE
Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36
Jinlian Chen, Xiaojie Lu, Kailin Zou, Kun Ye · 2013 · Journal of Lipid Research
The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model
Yiyi Hu, Guoping Du, Guohua Li, Xuetao Peng, Zhiqiao Zhang, Yingji Zhai · 2019 · Archives of Physiology and Biochemistry
Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr−/− mice
Donald Β. Jump, Christopher M. Depner, Sasmita Tripathy, Kelli A. Lytle · 2015 · Proceedings of The Nutrition Society
Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats
Shiho Arima, Hirofumi Uto, Rie Ibusuki, Ryo Kumamoto, Shirou Tanoue, Seiichi Mawatari, Kohei Oda, Masatsugu Numata, Hiroshi Fujita, Makoto Oketani et al. · 2013 · International Journal of Molecular Medicine
Liver X receptor α induces 17β-hydroxysteroid dehydrogenase-13 expression through SREBP-1c
Wen Su, Jun Peng, Sha Li, Yu-bing Dai, Chun-jiong Wang, Hu Xu, Min Gao, Xiong Zhong Ruan, Jan-Ακε Gustafsson, Youfei Guan et al. · 2017 · American Journal of Physiology-Endocrinology and Metabolism
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype
Nicole Golob‐Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, Sonja M. Kessler, Julia Judith Unterluggauer, Stefanie Krassnig, Kensuke Kojima, Xintong Chen, Yujin Hoshida, Nabeel M. Bardeesy et al. · 2018 · Translational Oncology
Pathogenesis of and major animal models used for nonalcoholic fatty liver disease
Mingzuo Jiang, Nan Wu, Xi Chen, Weijie Wang, Yi Chu, Hao Liu, Wenjiao Li, Di Chen, Xiaowei Li, Bing Xu · 2019 · Journal of International Medical Research
Apolipoprotein A-IV involves in glucose and lipid metabolism of rat
Zhenguo Wang, Lu Wang, Zhuzhen Zhang, Li Feng, Xue Ying Song, Jiarui Wu · 2019 · Nutrition & Metabolism
Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases
Juan Li, Tongxin Wang, Jun Xia, Weilei Yao, Feiruo Huang · 2019 · The FASEB Journal
PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis
Kangpeng Jin, Yang Liu, Yuze Shi, Haitian Zhang, Yuanyuan Sun, Guangyan Zhangyuan, Fei Wang, Weiwei Yu, Jincheng Wang, Xuewen Tao et al. · 2020 · Theranostics
α-Linolenic Acid-Enriched Cold-Pressed Perilla Oil Suppress High-Fat Diet-Induced Hepatic Steatosis through Amelioration of the ER Stress-Mediated Autophagy
Su Ji Bae, Ji Eun Kim, Hyeon Jun Choi, Yun Ju Choi, Su Jin Lee, Jeong Eun Gong, Sungbaek Seo, Seung Yun Yang, Beum‐Soo An, Hee Seob Lee et al. · 2020 · Molecules
Trans-omic analysis reveals obesity-associated dysregulation of inter-organ metabolic cycles between the liver and skeletal muscle
Riku Egami, Toshiya Kokaji, Atsushi Hatano, Katsuyuki Yugi, Miki Eto, Keigo Morita, Satoshi Ohno, Masashi Fujii, Ken‐ichi Hironaka, Saori Uematsu et al. · 2021 · iScience
Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway
Jingyi Luo, Pengbo Sun, Yangyang Wang, Yang Chen, Yaoyun Niu, Yipei Ding, Naihan Xu, Yaou Zhang, Weidong Xie · 2021 · European Journal of Pharmacology
The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
Niels van Best, Peter L. M. Jansen, Sander S. Rensen · 2015 · Hepatology International
Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice
Giridhar Kanuri, Marianne Landmann, Josephine Priebs, Astrid Spruss, Marina Löscher, Doreen Ziegenhardt, Carolin Röhl, Christian Degen, Ina Bergheim · 2015 · European Journal of Nutrition
Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
Zhaolian Bian, Xiong Ma · 2012 · Frontiers in Physiology
Dietary walnut oil modulates liver steatosis in the obese Zucker rat
Anja Fink, Corinna E. Rüfer, Julie Le Grandois, Alexander Röth, Dalal Werner, Eric Marchioni, Achim Bub, Stefan Barth · 2013 · European Journal of Nutrition
High-fat but not sucrose intake is essential for induction of dyslipidemia and non-alcoholic steatohepatitis in guinea pigs
David Højland Ipsen, Pernille Tveden‐Nyborg, Bidda Charlotte Rolin, Günaj Rakipovski, Maria Julia Beck, Line Winther Mortensen, Lasse Færk, Peter M. H. Heegaard, Peter Möller, Jens Lykkesfeldt · 2016 · Nutrition & Metabolism
PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis
Xiao Hu, Naoki Tanaka, Ran Guo, Lu Yu, Takero Nakajima, Frank J. Gonzalez, Toshifumi Aoyama · 2016 · The Journal of Nutritional Biochemistry
Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease
Xuelin Zhang, Yang Wang, Pingsheng Liu · 2016 · Protein & Cell
Western Diet-Fed ApoE Knockout Male Mice as an Experimental Model of Non-Alcoholic Steatohepatitis
Felipe Nunes de Camargo, Sandro Leão Matos, Layanne C. C. Araujo, Carla Roberta de Oliveira Carvalho, Andressa G. Amaral, João Paulo Camporez · 2022 · Current Issues in Molecular Biology
Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in metabolic dysfunction-associated steatohepatitis
Patcharamon Seubnooch, Matteo Montani, Jean‐François Dufour, Mojgan Masoodi · 2024 · Journal of Lipid Research
Liraglutide reduces lipid accumulation in steatotic L-02 cells by enhancing autophagy
SHI-WEI ZHOU, Man Zhang, MIN ZHU · 2014 · Molecular Medicine Reports
Chromatin variation associated with liver metabolism is mediated by transposable elements
Juan Du, Amy Leung, Candi Trac, Michael Lee, Brian W. Parks, Aldons Jake Lusis, Rama D Natarajan, Dustin E. Schones · 2016 · Epigenetics & Chromatin
Bisphenol A promotes hepatic lipid deposition involving Kupffer cells M1 polarization in male mice
Qiong Lv, Rufei Gao, Chuan Peng, Juan Yi, Lulu Liu, Shumin Yang, Danting Li, Jinbo Hu, Ting Luo, Mei Mei et al. · 2017 · Journal of Endocrinology
Folic Acid Supplementation Attenuates Chronic Hepatic Inflammation in High‐Fat Diet Fed Mice
Victoria Sid, Yue Shang, Yaw Loong Siow, Susara Madduma Hewage, James Duncan House, O Karmin · 2018 · Lipids
Mono-2-ethylhexyl phthalate induces the expression of genes involved in fatty acid synthesis in HepG2 cells
Jianying Bai, Zhen He, Yaofu Li, Xuexia Jiang, Hongmei Yu, Qing Tan · 2019 · Environmental Toxicology and Pharmacology
Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice
Yang Pan, Youlin Wang, Weiqing Tang, Weiwei Sun, Yinyan Ma, Shu Lin, Jia Jing, Long Jiang, Hang Shi, Zhiyuan Song et al. · 2020 · Scientific Reports
Neuromedin U, a Key Molecule in Metabolic Disorders
Hitoshi Teranishi, Reiko Hanada · 2021 · International Journal of Molecular Sciences
Ferulic Acid and P-Coumaric Acid Synergistically Attenuate Non-Alcoholic Fatty Liver Disease through HDAC1/PPARG-Mediated Free Fatty Acid Uptake
Kaili Cui, Lichao Zhang, Xiaoqin La, Haili Wu, Ruipeng Yang, Hanqing Li, Zhuoyu Li · 2022 · International Journal of Molecular Sciences
1,8-Cineole Ameliorates Steatosis of Pten Liver Specific KO Mice via Akt Inactivation
Soichiro Murata, Koichi Ogawa, Takashi Matsuzaka, Mitsuru Chiba, Ken Nakayama, Kenichi Iwasaki, Tomohiro Kurokawa, Naoki Sano, Tomohito Tanoi, Nobuhiro Ohkohchi · 2015 · International Journal of Molecular Sciences
Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
Zheng Chen, Mark J. Canet, Liang Sheng, Lin Jiang, Yi Xiong, Lei Yin, Liangyou Rui · 2015 · Molecular Metabolism
Vibrational signatures to discriminate liver steatosis grades
Chengyuan Peng, Franck Chiappini, Slávka Kaščáková, Mélanie Danulot, Christophe Sandt, Didier Samuel, P. Dumas, Catherine Guettier, François Le Naour · 2014 · The Analyst
Nogo‐B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate–activated protein kinase alpha–dependent pathway
Wenquan Hu, Wenwen Zhang, Yuanli Chen, Ujala Rana, Ru‐Jeng Teng, Yajun Duan, Zhong Liu, Baofeng Zhao, Jamie Foeckler, Hartmut Weiler-Guettler et al. · 2016 · Hepatology
Promising therapies for treatment of nonalcoholic steatohepatitis
Mazen Noureddin, Alice Zhang, Rohit Seth Loomba · 2016 · Expert Opinion on Emerging Drugs
Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests
Agostino Di Ciaula, Giuseppe Calamita, Harshitha Shanmugam, Mohamad Khalil, Leonilde Bonfrate, David Q.‐H. Wang, György Baffy, Piero Portincasa · 2021 · International Journal of Molecular Sciences
PPARα Senses Bisphenol S to Trigger EP300-Mediated Autophagy Blockage and Hepatic Steatosis
Jingjia Liang, Cheng Yu Xu, Jin Xu, Changjie Yang, Weirui Kong, Zhihao Xiao, Xiu Chen, Qian Liu, Zhenkun Weng, Jun Wang et al. · 2023 · Environmental Science & Technology
I148 M variant in PNPLA 3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease
Jin‐Ho Park, Belong Cho, Hyuktae Kwon, Daria Prilutsky, Jae Moon Yun, Ho-Chun Choi, Kyu‐Baek Hwang, In‐Hee Lee, Jong‐Il Kim, Sek Won Kong · 2015 · Liver International
Transcriptome Analysis on the Inflammatory Cell Infiltration of Nonalcoholic Steatohepatitis in Bama Minipigs Induced by a Long-Term High-Fat, High-Sucrose Diet
Ji‐Han Xia, Jing Yuan, Leilei Xin, Yuanyuan Zhang, Siyuan Kong, Yaoxing Chen, Shulin Yang, Kui Li · 2014 · PLoS ONE
The impact of PNPLA 3 (rs738409 C>G) polymorphisms on liver histology and long‐term clinical outcome in chronic hepatitis B patients
Willem Pieter Brouwer, Adriaan J van der Meer, André Boonstra, Suzan D. Pas, Robert Jacobus de Knegt, Rob A. de Man, Bettina E. Hansen, Fiebo J.W. ten Kate, Harry L.A. Janssen · 2014 · Liver International
Phospholipase D1 deficiency in mice causes nonalcoholic fatty liver disease via an autophagy defect
Jang Ho Hur, Shi‐Young Park, Claudia Dall’Armi, Jae‐Sung Lee, Gilbert Di Paolo, Hui‐Young Lee, Mee‐Sup Yoon, Do Sik Min, Cheol Soo Choi · 2016 · Scientific Reports
Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation
Tianran Shen, Xu Chen, Yan‐Ping Li, Xilan Tang, Xinwei Jiang, Chao Yu, Yuanzhu Zheng, Honghui Guo, Wenhua Ling · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis
Long Wang, Mian Li, Zhiyun Zhao, Min Xu, Jieli Lu, Tiange Wang, Yuhong Chen, Shuangyuan Wang, Meng Dai, Yanan Hou et al. · 2018 · The American Journal of Medicine
Molecular Genetics of Keratinization Disorders – What’s New About Ichthyosis
Jouni Uitto, Leila Youssefian, Amir Hossein Saeidian, Hassan Vahidnezhad · 2020 · Acta Dermato Venereologica
Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
David Fernández‐Ramos, Fernando Lopitz‐Otsoa, Laura delaCruz‐Villar, Jon Bilbao, Martina Pagano, Laura Mosca, Maider Bizkarguenaga, Marina Serrano‐Maciá, Mikel Azkargorta, Marta Iruarrizaga‐Lejarreta et al. · 2020 · World Journal of Gastroenterology
Bisphenol A induces hepatic triglyceride level in adult male rare minnow Gobiocypris rarus
Kaihang Mi, Xi Chen, Kaiyuan Lu, Yujie Zhu, Meng Zhang, Hui Yang, Wenzhi Wei, Yingying Zhang · 2021 · Ecotoxicology and Environmental Safety
Increased Hepatic Lipogenesis Elevates Liver Cholesterol Content
Jean-Mathieu Berger, Young-Ah Moon · 2021 · Molecules and Cells
Hepatic galectin-3 is associated with lipid droplet area in non-alcoholic steatohepatitis in a new swine model
Luis Vicente Herrera-Marcos, Roberto Martínez‐Beamonte, Manuel Macías-Herranz, Carmen Arnal, Cristina Barranquero, Juan José Puente‐Lanzarote, Sonia Gascón, Tania Herrero‐Continente, Gonzalo Gonzalo, Víctor Alastrué-Vera et al. · 2022 · Scientific Reports
Hepatocyte-Specific Ptpn6 Deletion Promotes Hepatic Lipid Accretion, but Reduces NAFLD in Diet-Induced Obesity: Potential Role of Pparγ
Elaine Xu, Marie‐Pier Forest, Michael G. Schwab, Rita Kohen Avramoglu, Emmanuelle St-Amand, Annabelle Z. Caron, Kerstin Bellmann, Michaël Shum, Grégory Voisin, Marilène Paquet et al. · 2013 · Hepatology
Gut‐derived lymphocyte recruitment to liver and induce liver injury in non‐alcoholic fatty liver disease mouse model
Ying Chuan Hu, Henghui Zhang, Jing Li, Cong Xu, Yanhui Chen, Gaixia He, Yujing Chi, Yulan Liu · 2015 · Journal of Gastroenterology and Hepatology
Ablation of carotenoid cleavage enzymes (BCO1 and BCO2) induced hepatic steatosis by altering the farnesoid X receptor/miR-34a/sirtuin 1 pathway
Ji Ye Lim, Chun Liu, Kang‐Quan Hu, Donald E. Smith, Xiangdong Wang · 2018 · Archives of Biochemistry and Biophysics
Hepsin enhances liver metabolism and inhibits adipocyte browning in mice
Shuo Li, Jianhao Peng, Hao Wang, Wei Zhang, Jonathan Mark Brown, Yiqing Zhou, Qingyu Wu · 2020 · Proceedings of the National Academy of Sciences
Histone Modifications in NAFLD: Mechanisms and Potential Therapy
Yulei Shi, Wei Qi · 2023 · International Journal of Molecular Sciences
Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease
Zhenzhen Fang, Gang Shen, Yina Wang, Fuyan Hong, Xiumei Tang, Yongcheng Zeng, Ting Zhang, Huanyi Liu, Yanmei Li, Jinhong Wang et al. · 2024 · Signal Transduction and Targeted Therapy
Central effects of humanin on hepatic triglyceride secretion
Zhenwei Gong, Kai Su, Lingguang Cui, Emir Tas, Ting Zhang, H. Henry Dong, Shoshana Yakar, Radhika H. Muzumdar · 2015 · American Journal of Physiology-Endocrinology and Metabolism
Modulation of hepatic redox status and mitochondrial metabolism by exercise: Therapeutic strategy for liver diseases
António A.M.R. Ascensão, Maria João Martins, Estela Santos Alves, Inês Oliveira Gonçalves, Piero Portincasa, Paulo Jorge Oliveira, José Magalhães · 2013 · Mitochondrion
Apolipoprotein C3(-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population
Min-Rui Li · 2014 · World Journal of Gastroenterology
Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis
Jihong Lian, Wesam Bahitham, Rashmi Panigrahi, Randal Nelson, Lena Li, Russell Watts, Aducio Thiesen, M. Joanne Lemieux, Richard S. Lehner · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids